Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-Dose Oral Imatinib in the Treatment of Scleroderma Pulmonary Involvement: A Phase II Pilot Study

NCT00573326 is registered in ClinicalTrials.gov with Azienda Ospedaliera Universitaria Policlinico as lead sponsor.

NCT NCT00573326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00573326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-Dose Oral Imatinib in the Treatment of Scleroderma Pulmonary Involvement: A Phase II Pilot Study
Lead sponsor
Azienda Ospedaliera Universitaria Policlinico
Phase
Phase 2
Overall status
Unknown status
Start date
February 28, 2009
Completion date
June 30, 2010
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

systemic sclerosis